Investing Profile

Heath Lukatch

VCInvestorFounder

Partner at Novo Holdings

redtreevc.com/team/San Francisco, California

Your Intro Paths to Heath Lukatch

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Networks Heath is a member of

Hotmail Network

4900 CONNECTIONS

Hotmail Network

4900 CONNECTIONS

Stanford University Network

925 CONNECTIONS

University of California, Berkeley Network

501 CONNECTIONS

TPG Network

41 CONNECTIONS

Find Heath Lukatch on

cb

Current Investing Position

Novo Holdings Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

25

Heath Lukatch is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)Consumer Health (Seed)San Francisco Bay Area Pharmaceuticals (Pre-seed)Health IT (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Consumer Health (Pre-seed)Health & Hospital Services (Pre-seed)Therapeutics (Seed)Therapeutics (Pre-seed)Health IT (Seed)Digital Health (Seed)Health & Hospital Services (Seed)

Heath Lukatch's Investments On Record (20)

Company	StageDateRound Size	Total Raised
Excellergy	Series AOct 2025$70M	$70M
Engrail Therapeutics	Series BMar 2024$160M	$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Peter Bisgaard (Pivotal bioVenture Partners), Jasper Bos (Forbion), Niall O’Donnell (RiverVest)
Tachyon Therapeutics	Series AMar 2023$12M	$12M
Alladapt Immunotherapeutics	Series UnknownJun 2022$120M	$230M
Co-investors: Jeff Weiner (Next Play Ventures), Anne Wojcicki (23andMe), Himani Bhalla (Hercules Capital)
Magnus Medical	Series AOct 2021$25M	$25M
Co-investors: Andrew Firlik (Jazz Venture Partners)
Acrigen Biosciences	SeedSep 2021
ViaCyte	Series DNov 2018$80M	$140M
Co-investors: Adam Koppel (Bain Capital Life Sciences), Asish Xavier (Johnson & Johnson Innovation)
Halo Neuroscience	Series BJan 2018$13M	$24M
Co-investors: Fabrice Grinda (FJ Labs), Marc Andreessen (Andreessen Horowitz), Jeff Clavier (Uncork Capital), Patrick Chung (Xfund), Patrick S. Chung

Heath Lukatch's Media (1)

Red Tree Venture Capital Announces Closing of $272 Million Inaugural Fund

www.globenewswire.com

Heath Lukatch's Experience

Board Member AnaptysBioPresent

Board Observer HotmailPresent

Board Member Foldrx PharmaceuticalsPresent

Chairman Of The Board HotmailPresent

Board Member Flexion TherapeuticsPresent

Board Observer SI-BONEPresent

Chairman Of The Board Spinifex Pharmaceuticals Inc.Present

Chairman Of The Board Satsuma Pharmaceuticals, Inc.Present

Board Member VaxcytePresent

Board Member Ceribell │ AI-Powered Point-of-Care EEGPresent

Board Member ViaCytePresent

Chairman of the Board MagnusPresent

Board Member CARGO TherapeuticsPresent

Board Member ExcellergyPresent

Board Observer Ceribell │ AI-Powered Point-of-Care EEGPresent

Chairman of the Board Acrigen BiosciencesPresent

Board Observer Alladapt Immunotherapeutics, Inc.Present

Board Member Bicara TherapeuticsPresent

Board Member Engrail TherapeuticsPresent

CEO and Founder AutoMate ScientificPresent

Managing Director and Founder 10K Lakes CapitalPresent

Partner Novo HoldingsPresent

Partner and Managing Director, TPG Biotech TPGPresent

Partner, TPG Growth and RISE TPGPresent

Founder & Managing Partner Red Tree Venture CapitalPresent

Heath Lukatch's Education

University of California, Berkeley B.A. Biochemistry

Stanford University Ph.D. Neuroscience

Investors who invest with Heath Lukatch

Heather Ludvigsen

Kenneth Harrison

Nik Economopoulos

Raymond Camahort

Founders who looked at Heath Lukatch's profile also looked at these Scouts & Angels

Christopher Priebe